HomeGreater Than Icon
Mercury Laboratories LtdGreater Than Icon
Mercury Laboratories Ltd Financials
Company Logo

Mercury Laboratories Ltd Financial Statement

Mercury Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue16.83
Operating Expense15.07
Net Profit0.34
Net Profit Margin2.02
Earning Per Share2.85
EBIDTA1.58
Effective Tax Rate22.73

Mercury Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual75.56
Operating Expenses Annual66.53
Operating Profit Annual10.12
Interest Annual0.38
Depreciation2.80
Net Profit Annual5.65
Tax Annual1.27

Mercury Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning7.32
Cash Flow from Operations8.23
Cash Flow from Investing-6.27
Cash Flow from Financing-1.04
Cash Flow at the End8.23

Mercury Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)13.39
PBIT Margin (%)9.66
PBT Margin (%)-15.76
Net PROFIT Margin (%)7.48
Return On Networth / Equity (%)11.71
Return On Networth /Employed (%)13.54
Return On Assets (%)10.47
Total Debt / Equity (X)0.12
Asset Turnover Ratio (%)1.40

Mercury Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual24.03
Total Current Assets Annual39.84
Non Current Assets Annual28.12
Total Shareholders Funds Annual50.84
Total Assets Annual67.96

Mercury Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, Mercury Laboratories Ltd has a market capitalization of 99.85 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Mercury Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.11.
In FY 2023 , Mercury Laboratories Ltd recorded a total revenue of approximately 75.56 Cr marking a significant milestone in the company's financial performance.
Mercury Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..
Mercury Laboratories Ltd's current PE ratio is 17.67.
Mercury Laboratories Ltd's ROCE averaged 13.3% from the FY ending March 2022 to 2024, with a median of 13.0%. It peaked at 15.2% in March 2023, reflecting strong capital efficiency over the period..
Mercury Laboratories Ltd's latest EBIT is Rs. 7.30 Cr, surpassing the average EBIT of Rs. 6.86 Cr over the 5 years..